Evidence for reinitiation of proliferative activity following alkylation or radiation.
D000477:Alkylating Agents / Q000494:pharmacology*; D000818:Animals; D000963:Antimetabolites / Q000494:pharmacology*; D002330:Carmustine / Q000494:pharmacology / Q000627:therapeutic use; D002455:Cell Division / Q000187:drug effects / Q000528:radiation effects; D004305:Dose-Response Relationship, Drug; D005472:Fluorouracil / Q000494:pharmacology / Q000627:therapeutic use; D006412:Hematopoietic Stem Cells / Q000187:drug effects / Q000528:radiation effects; D006918:Hydroxyurea / Q000494:pharmacology / Q000627:therapeutic use; D008223:Lymphoma / Q000188:drug therapy / Q000532:radiotherapy; D008466:Mechlorethamine / Q000494:pharmacology / Q000627:therapeutic use; D051379:Mice; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000532:radiotherapy
D000477:Alkylating Agents; D000963:Antimetabolites; D008466:Mechlorethamine; D005472:Fluorouracil; D002330:Carmustine; D006918:Hydroxyurea